{"id":"https://openalex.org/W2467249055","doi":"https://doi.org/10.17816/ov9259-68","title":"Taflotan, the first preservative-free prostaglandin F2\u03b1 analogue: treatment advantages in primary open-angle glaucoma patients","display_name":"Taflotan, the first preservative-free prostaglandin F2\u03b1 analogue: treatment advantages in primary open-angle glaucoma patients","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-15","ids":{"openalex":"https://openalex.org/W2467249055","doi":"https://doi.org/10.17816/ov9259-68","mag":"2467249055"},"language":"en","primary_location":{"id":"doi:10.17816/ov9259-68","doi":"https://doi.org/10.17816/ov9259-68","is_oa":true,"landing_page_url":"https://doi.org/10.17816/ov9259-68","pdf_url":null,"source":{"id":"https://openalex.org/S4210170935","display_name":"Ophthalmology Reports","issn_l":"1998-7102","issn":["1998-7102","2412-5423"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-2"],"host_organization":"https://openalex.org/P4310312788","host_organization_name":"ECO-vector","host_organization_lineage":["https://openalex.org/P4310312788"],"host_organization_lineage_names":["ECO-vector"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2467249055"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.17816/ov9259-68","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111009135","display_name":"Sergey Yu. Astakhov","orcid":"https://orcid.org/0000-0003-0777-4861","observed_orcids":["https://orcid.org/0000-0003-0777-4861"]},"institutions":[{"id":"https://openalex.org/I2799540354","display_name":"First Pavlov State Medical University of St. Petersburg","ror":"https://ror.org/04g525b43","country_code":"RU","type":"education","lineage":["https://openalex.org/I2799540354"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Sergey Yu Astakhov","raw_affiliation_strings":["First Pavlov State Medical University of St Petersburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Pavlov State Medical University of St Petersburg","institution_ids":["https://openalex.org/I2799540354"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022472599","display_name":"Natalia V. Tkachenko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799540354","display_name":"First Pavlov State Medical University of St. Petersburg","ror":"https://ror.org/04g525b43","country_code":"RU","type":"education","lineage":["https://openalex.org/I2799540354"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Natalia V Tkachenko","raw_affiliation_strings":["First Pavlov State Medical University of St Petersburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Pavlov State Medical University of St Petersburg","institution_ids":["https://openalex.org/I2799540354"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2799540354"],"apc_list":null,"apc_paid":null,"fwci":0.5456,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.64215943,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":97},"biblio":{"volume":"9","issue":"2","first_page":"59","last_page":"68"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.07739999890327454,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/preservative-free-eye-drops","display_name":"preservative-free eye drops","score":0.9580000042915344},{"id":"https://openalex.org/keywords/prostaglandin-f2alpha-analogue","display_name":"prostaglandin F2alpha analogue","score":0.8880000114440918},{"id":"https://openalex.org/keywords/primary-open-angle-glaucoma","display_name":"primary open-angle glaucoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/latanoprost","display_name":"latanoprost","score":0.8939999938011169},{"id":"https://openalex.org/keywords/benzalkonium-chloride","display_name":"benzalkonium chloride","score":0.953000009059906},{"id":"https://openalex.org/keywords/intraocular-pressure-reduction","display_name":"intraocular pressure reduction","score":0.8090000152587891},{"id":"https://openalex.org/keywords/corneal-staining","display_name":"corneal staining","score":0.9020000100135803},{"id":"https://openalex.org/keywords/conjunctival-hyperemia","display_name":"conjunctival hyperemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/tear-film","display_name":"tear film","score":0.6850000023841858},{"id":"https://openalex.org/keywords/tear-film-break-up-time","display_name":"tear film break-up time","score":0.8140000104904175},{"id":"https://openalex.org/keywords/corneal-epithelium","display_name":"corneal epithelium","score":0.8730000257492065},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C2775919038","wikidata":"https://www.wikidata.org/wiki/Q108126784","display_name":"Benzalkonium chloride","level":2,"score":0.9094549417495728},{"id":"https://openalex.org/C2776740260","wikidata":"https://www.wikidata.org/wiki/Q634959","display_name":"Latanoprost","level":3,"score":0.8934335708618164},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6879295706748962},{"id":"https://openalex.org/C2779526769","wikidata":"https://www.wikidata.org/wiki/Q4859319","display_name":"Prostaglandin analogue","level":3,"score":0.630588710308075},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.6259942054748535},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6130666732788086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5763240456581116},{"id":"https://openalex.org/C2991803831","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Open angle glaucoma","level":3,"score":0.5662794709205627},{"id":"https://openalex.org/C2780276452","wikidata":"https://www.wikidata.org/wiki/Q2193376","display_name":"Travoprost","level":4,"score":0.560513436794281},{"id":"https://openalex.org/C2776882836","wikidata":"https://www.wikidata.org/wiki/Q168291","display_name":"Cornea","level":2,"score":0.5101921558380127},{"id":"https://openalex.org/C67031304","wikidata":"https://www.wikidata.org/wiki/Q274579","display_name":"Preservative","level":2,"score":0.45971089601516724},{"id":"https://openalex.org/C2778837293","wikidata":"https://www.wikidata.org/wiki/Q3320636","display_name":"Artificial tears","level":2,"score":0.4353974163532257},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2351735532283783},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1546933650970459},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.15197226405143738},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06327533721923828},{"id":"https://openalex.org/C31903555","wikidata":"https://www.wikidata.org/wiki/Q1637030","display_name":"Food science","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.17816/ov9259-68","doi":"https://doi.org/10.17816/ov9259-68","is_oa":true,"landing_page_url":"https://doi.org/10.17816/ov9259-68","pdf_url":null,"source":{"id":"https://openalex.org/S4210170935","display_name":"Ophthalmology Reports","issn_l":"1998-7102","issn":["1998-7102","2412-5423"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-2"],"host_organization":"https://openalex.org/P4310312788","host_organization_name":"ECO-vector","host_organization_lineage":["https://openalex.org/P4310312788"],"host_organization_lineage_names":["ECO-vector"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology Reports","raw_type":"journal-article"},{"id":"mag:2617863185","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/taflotan-pervyy-analog-prostaglandina-f2-bez-konservanta-preimuschestva-v-lechenii-bolnyh-pervichnoy-otkrytougolnoy-glaukomoy/pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401404","display_name":"CyberLeninK (CyberLeninka)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u041e\u0444\u0442\u0430\u043b\u044c\u043c\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0432\u0435\u0434\u043e\u043c\u043e\u0441\u0442\u0438","raw_type":null}],"best_oa_location":{"id":"doi:10.17816/ov9259-68","doi":"https://doi.org/10.17816/ov9259-68","is_oa":true,"landing_page_url":"https://doi.org/10.17816/ov9259-68","pdf_url":null,"source":{"id":"https://openalex.org/S4210170935","display_name":"Ophthalmology Reports","issn_l":"1998-7102","issn":["1998-7102","2412-5423"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-2"],"host_organization":"https://openalex.org/P4310312788","host_organization_name":"ECO-vector","host_organization_lineage":["https://openalex.org/P4310312788"],"host_organization_lineage_names":["ECO-vector"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W185887293","https://openalex.org/W1577124635","https://openalex.org/W1964605819","https://openalex.org/W1966829052","https://openalex.org/W1969752160","https://openalex.org/W1972384545","https://openalex.org/W1975117853","https://openalex.org/W1978986531","https://openalex.org/W1984656953","https://openalex.org/W1988430503","https://openalex.org/W1988519672","https://openalex.org/W2000078179","https://openalex.org/W2010339712","https://openalex.org/W2010842159","https://openalex.org/W2012662427","https://openalex.org/W2012790600","https://openalex.org/W2015733557","https://openalex.org/W2018620325","https://openalex.org/W2033650789","https://openalex.org/W2037682190","https://openalex.org/W2056411236","https://openalex.org/W2065985817","https://openalex.org/W2068119665","https://openalex.org/W2069566480","https://openalex.org/W2082340321","https://openalex.org/W2092601188","https://openalex.org/W2108069709","https://openalex.org/W2132853895","https://openalex.org/W2133230431","https://openalex.org/W2133869642","https://openalex.org/W2148801742","https://openalex.org/W2154145465","https://openalex.org/W2435369431","https://openalex.org/W4240772735"],"related_works":["https://openalex.org/W2033650789","https://openalex.org/W2038852034","https://openalex.org/W2157904903","https://openalex.org/W2017145123","https://openalex.org/W2047290832","https://openalex.org/W2022423955","https://openalex.org/W2065056198","https://openalex.org/W1965340875","https://openalex.org/W4321322020","https://openalex.org/W2298976441"],"abstract_inverted_index":{"Over":[0],"the":[1,5,12,19,54,71,95,109,123],"past":[2],"15":[3],"years,":[4],"negative":[6,120],"role":[7],"of":[8,21,64,87,94],"toxic":[9],"preservatives":[10],"in":[11,18,82],"IOP-lowering":[13,48],"eye":[14,49,75],"drops":[15,50],"solutions":[16],"used":[17],"treatment":[20,130],"primary":[22],"open":[23],"angle":[24],"glaucoma":[25],"(POAG)":[26],"patients":[27,66],"has":[28],"been":[29],"convincingly":[30],"proven":[31],"by":[32,105],"many":[33],"national":[34],"and":[35,85,99,126],"foreign":[36],"experts.":[37],"Therefore,":[38],"there":[39],"is":[40,53],"a":[41,79],"worldwide":[42],"tendency":[43],"to":[44,68],"prescribe":[45],"preferably":[46],"preservative-free":[47,57],"nowadays.":[51],"Taflotan":[52,69],"world\u2019s":[55],"first":[56],"prostaglandin":[58],"F2a":[59],"analogue.":[60],"In":[61],"our":[62],"study":[63],"POAG":[65],"switched":[67],"from":[70],"benzalkonium":[72],"chloride-preserved":[73],"latanoprost":[74],"drops,":[76],"we":[77],"observed":[78],"marked":[80],"decrease":[81],"corneal":[83,100],"staining":[84],"severity":[86],"conjunctival":[88],"hyperemia,":[89],"as":[90,92],"well":[91],"increase":[93],"tear":[96,124],"breakup":[97],"time":[98],"epithelium":[101],"morphology":[102],"improvement":[103],"evaluated":[104],"confocal":[106],"tomography.":[107],"Thus,":[108],"drug":[110],"not":[111],"only":[112],"effectively":[113],"lowers":[114],"IOP":[115],"but":[116],"also":[117],"produces":[118],"less":[119],"effect":[121],"on":[122],"film":[125],"eyeball":[127],"surface,":[128],"improving":[129],"tolerability.":[131]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2467249055","counts_by_year":[{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-07-22T00:00:00"}
